Skip to main content

Corporate insider profile

Neal C Bradsher Insider Trades

Neal C Bradsher has reported 4 open-market purchases on SEC Form 4 and is a net buyer of $9,455,818 across 2 companies. The most recent open-market transaction was reported on Nov 17, 2026. Source: SEC Form 4 filings.

Latest reported as Corporate insider of Lineage Cell Therapeutics, Inc. (LCTX).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
4
Reported companies
2
Net open-market value
$9,455,818
Latest transaction
Nov 17, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Nov 17, 2026Lineage Cell Therapeutics, Inc. (LCTX)Corporate insiderOpen Market Purchase1,000,000$0.77$770,700
Nov 17, 2026Insight Molecular Diagnostics Inc. (IMDX)Corporate insiderOpen Market Purchase3,428,571$1.75$5,999,999
Apr 27, 2026Insight Molecular Diagnostics Inc. (IMDX)Corporate insiderOpen Market Purchase570,184$3.56$2,032,250
Apr 20, 2026Insight Molecular Diagnostics Inc. (IMDX)Corporate insiderOpen Market Purchase182,861$3.57$652,869

Common questions

Neal C Bradsher insider trading FAQ

Is Neal C Bradsher buying or selling stock?
Across all SEC Form 4 open-market filings on record, Neal C Bradsher is a net buyer of $9,455,818, with 4 open-market purchases reported. The latest transaction was reported on Nov 17, 2026.
Which companies does Neal C Bradsher report insider trades for?
Neal C Bradsher has reported open-market trades in Lineage Cell Therapeutics, Inc. (LCTX), Insight Molecular Diagnostics Inc. (IMDX). The latest SEC-reported relationship is Corporate insider of Lineage Cell Therapeutics, Inc. (LCTX).
Where does Neal C Bradsher's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1278388, and refreshes this page daily.